Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of IDXG will - over the next 2 Weeks and hit - by . In that time frame, IDXG's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
IDXG shares rose +0.51% in Tuesday, July 28, 2026's trading session, rising from a previous close of $1.54 to move at $1.55. The stock demonstrated notable intraday movement (see IDXG's key stats for a full breakdown), fluctuating between $1.51 and $1.55, a +2.81% trading range. While recent weeks have seen some volatility, IDXG has managed to secure a -4.17% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.7K shares changing hands, 1.38K more than the previous session. This amounted to $2.64K in total market activity.
Will IDXG Continue Its Trend?
According to analyst ratings and projections for IDXG, Interpace Biosciences, Inc. shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators currently suggest a bearish sentiment for IDXG. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the IDXG stock forecast, now is not the best time to buy IDXG stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on IDXG covering social and institutional perspectives.
IDXG Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into IDXG's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.31% to 49.72%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 47.30%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.75%, maintains a neutral outlook for the long term. Insights into IDXG's shareholder base show how institutional investors are positioning themselves during these momentum shifts

